SFI
ONCY

SPC Financial Inc’s Oncolytics Biotech ONCY Stock Holding History

SPC Financial Inc’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$17.5K Buy
12,500
+2,500
+25% +$2.8K ﹤0.01% 278
2025
Q2 		$7.73K Buy
+10,000
New +$5.3K ﹤0.01% 262

Other funds holding ONCY

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

SPC Financial Inc's ONCY Position: Q3 2025 in Review

SPC Financial Inc increased its Oncolytics Biotech (ONCY) stake by 25% in Q3 2025, buying an estimated $2.8K and bringing the position to 12,500 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #278.

SPC Financial Inc first reported a position in ONCY in Q2 2025 and has held it in 2 quarters since. 56 funds tracked by Wall St. Rank hold ONCY as of Q3 2025.

  • SPC Financial Inc held 12,500 shares of Oncolytics Biotech worth $17.5K as of Q3 2025.
  • SPC Financial Inc bought 2,500 Oncolytics Biotech shares in Q3 2025, an estimated $2.8K.
  • Oncolytics Biotech made up ﹤0.01% of SPC Financial Inc's portfolio in Q3 2025, its #278 holding.
  • SPC Financial Inc first reported a position in Oncolytics Biotech in Q2 2025 and has held it in 2 quarters since.
  • 56 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2025.

Based on SPC Financial Inc's 13F filing for Q3 2025, filed 5 Nov 2025.